Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Estimating number of cases and spread of coronavirus disease (COVID-19) using critical care admissions, United Kingdom, February to March 2020.
JIT, M; JOMBART, T; NIGHTINGALE, ES; ENDO, A; ABBOTT, S; LSHTM Centre for Mathematical Modelling of Infecti,; EDMUNDS, WJ;
2020
EUROSURVEILLANCE, (2020).25 18 10.2807/1560-7917.ES.2020.25.18.2000632.
Challenges in control of COVID-19: short doubling times and long delay to effect of interventions.
Pellis, L; Scarabel, F; Stage, H; Overton, C; Chappell, L; Lythgoe, K; FEARON, E; Bennett, E; Curran-Sebastian, J; Das, R; Fyles, M; Lewkowicz, H; Pang, X; Vekaria, B; Webb, L; House, T; Hall, I;
2020
, Cold Spring Harbor Laboratory (2020). 10.1101/2020.04.12.20059972.
Evidence informing the UK's COVID-19 public health response must be transparent.
Alwan, NA; Bhopal, R; Burgess, RA; Colburn, T; Cuevas, LE; Smith, GD; Egger, M; Eldridge, S; GALLO, V; Gilthorpe, MS; Greenhalgh, T; Griffiths, C; Hunter, PR; Jaffar, S; Jepson, R; Low, N; Martineau, A; McCoy, D; Orcutt, M; Pankhania, B; Pikhart, H; Pollock, A; Scally, G; SMITH, J; Sridhar, D; ... 36 signatories,
2020
Lancet (London, England), (2020).395 10229 10.1016/S0140-6736(20)30667-X.
OpenSAFELY: impact of national guidance on switching from warfarin to direct oral anticoagulants (DOACs) in early phase of COVID-19 pandemic in England.
Curtis, HJ; MacKenna, B; Walker, AJ; Croker, R; Mehrkar, A; Morton, CE; Bacon, S; Hickman, G; Inglesby, P; Bates, C; Evans, D; Ward, T; Cockburn, J; Davy, S; BHASKARAN, K; SCHULTZE, A; RENTSCH, CT; WILLIAMSON, E; Hulme, W; MCDONALD, HI; TOMLINSON, L; MATHUR, R; Drysdale, H; EGGO, RM; WING, K; ... GOLDACRE, B.
2020
MedRxiv (2020). 10.1101/2020.12.03.20243535.
The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis.
Cilloni, L; FU, H; Vesga, JF; Dowdy, D; Pretorius, C; Ahmedov, S; Nair, SA; Mosneaga, A; Masini, E; Sahu, S; Arinaminpathy, N;
2020
EClinicalMedicine, (2020).28, 10.1016/j.eclinm.2020.100603.
Using volunteered geographic information to assess mobility in the early phases of the COVID-19 pandemic: a cross-city time series analysis of 41 cities in 22 countries from March 2nd to 26th 2020.
Vannoni, M; MCKEE, M; Semenza, JC; BONELL, C; Stuckler, D;
2020
GLOBALIZATION AND HEALTH, (2020).16 1 10.1186/s12992-020-00598-9.
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study.
Manson, JJ; Crooks, C; Naja, M; Ledlie, A; Goulden, B; Liddle, T; Khan, E; Mehta, P; Martin-Gutierrez, L; Waddington, KE; Robinson, GA; Ribeiro Santos, L; McLoughlin, E; Snell, A; Adeney, C; Schim van der Loeff, I; Baker, KF; Duncan, CJ A; Hanrath, AT; Lendrem, BC; De Soyza, A; Peng, J; J'Bari, H; Greenwood, M; Hawkins, E; ... Tattersall, RS.
2020
The Lancet Rheumatology, (2020).2 10 10.1016/S2665-9913(20)30275-7.
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic center.
Aitken, J; Ambrose, K; Barrell, S; Beale, R; Bineva-Todd, G; Biswas, D; Byrne, R; Caidan, S; Cherepanov, P; Churchward, L; Clark, G; Crawford, M; Cubitt, L; Dearing, V; Earl, C; Edwards, A; Ekin, C; Fidanis, E; Gaiba, A; Gamblin, S; Gandhi, S; Goldman, J; Goldstone, R; Grant, PR; Greco, M; ... Crick COVID-19 Consortium,
2020
Nature biotechnology, (2020).38 8 10.1038/s41587-020-0623-z.
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.
CLARK, A; JIT, M; WARREN-GASH, C; Guthrie, B; Wang, HH X; Mercer, SW; SANDERSON, C; MCKEE, M; Troeger, C; Ong, KL; CHECCHI, F; PEREL, P; Joseph, S; GIBBS, HP; Banerjee, A; EGGO, RM; Centre for the Mathematical Modelling of Infectiou,;
2020
The Lancet. Global Health, (2020).8 8 10.1016/S2214-109X(20)30264-3.
Benefit-risk analysis of health benefits of routine childhood immunisation against the excess risk of SARS-CoV-2 infections during the COVID-19 pandemic in Africa.
Abbas, K; Procter, SR; VAN ZANDVOORT, K; Clark, A; FUNK, S; Mengistu, T; Hogan, D; Dansereau, E; JIT, M; FLASCHE, S;
2020
(2020). 10.1101/2020.05.19.20106278.